Literature DB >> 6978364

Comparative effects of azathioprine, cyclophosphamide and frentizole on cellular immunity in mice.

S R Smith, C Terminelli, C T Kipilman, Y Smith.   

Abstract

This report extends previous observations on the immunosuppressive properties of cyclophosphamide (CPA), azathioprine and frentizole (15) to include murine models of cellular immunity. Systemic and local graft vs host reactions (GVHR) were most effectively suppressed by CPA. In contrast to frentizole, both CPA and azathioprine were found to inhibit the proliferation of parental T-cells in a systemic GVHR. However, CPA was the only agent capable of inhibiting the proliferation of T-cells following contact sensitization with oxazolone. Mice pretreated with a high dose of CPA or frentizole prior to inoculation with the murine sarcoma virus exhibited accelerated tumor growth. However, there was no accelerated growth of murine sarcoma virus induced tumors or an SaI spindle cell fibrosarcoma during rather prolonged therapy with immunosuppressive doses of CPA, azathioprine or frentizole. Normal mice treated with CPA showed a more drastic reduction in lymphoid elements of the spleen and thymus than mice treated with azathioprine or frentizole. Studies on the mitogenic responsiveness of spleen cells obtained from normal mice after an eight day course of therapy suggested that CPA has some selectivity of action on B-cells and azathioprine on T-cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6978364     DOI: 10.3109/08923978109026424

Source DB:  PubMed          Journal:  J Immunopharmacol        ISSN: 0163-0571


  5 in total

1.  Pharmacologic manipulation of graft versus host induced splenomegaly.

Authors:  R E Roudebush; H U Bryant
Journal:  Agents Actions       Date:  1992-03

2.  Plasma concentrations and organ distribution of thiopurines after oral application of azathioprine in mice.

Authors:  V Kurowski; H Iven
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

3.  Pharmacologic manipulation of a four day murine delayed type hypersensitivity model.

Authors:  R E Roudebush; H U Bryant
Journal:  Agents Actions       Date:  1993-01

Review 4.  Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer.

Authors:  L Bracci; G Schiavoni; A Sistigu; F Belardelli
Journal:  Cell Death Differ       Date:  2013-06-21       Impact factor: 15.828

5.  Thiopurine use associated with reduced B and natural killer cells in inflammatory bowel disease.

Authors:  James D Lord; Donna M Shows
Journal:  World J Gastroenterol       Date:  2017-05-14       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.